Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113185465A reveals a high-yield Stille coupling route for 4-ethyl-5-aminopyrimidine, offering significant cost reduction in pharmaceutical intermediate manufacturing through mild conditions.
Patent CN101486737A discloses a novel quaternary ammonium ferrocene ligand enabling high-yield asymmetric allylic substitution with simplified catalyst recovery for cost-effective manufacturing.
Novel 8-step synthetic route for Loxoprofen Sodium from p-methylacetophenone. High yield, solvent recovery, and scalable NSAID intermediate manufacturing technology.
Novel cyclopropanation method using diethylzinc and diiodomethane offers high yields and mild conditions for scalable API intermediate manufacturing.
Patent CN110002986A enables green water-phase oxidation. Eliminates organic solvents for cost reduction. Reliable supply chain for high-purity fluorenone intermediates.
Novel cobalt-catalyzed CO2 carboxylation patent offers cost-effective route for high-purity isonicotinic acid intermediates, enhancing supply chain reliability for global pharma manufacturing.
Patent CN102659705A reveals a novel base-mediated route for 3,4-disubstituted isoxazoles, offering high yields and simplified supply chains for drug manufacturing.
Patent CN107235995B details a cobalt-catalyzed asymmetric hydrosilylation method offering high enantioselectivity and cost reduction in organosilicon manufacturing for global supply chains.
Patent CN103864878A reveals a novel cross-coupling method for Abiraterone Acetate using organozinc reagents, offering significant cost reduction and improved purity for pharmaceutical intermediates manufacturing.
Patent CN116655503B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable methods.
Patent CN120208942A reveals a novel synthesis route for C2 symmetric ligands. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN107935912B reveals a safer, non-NaH route for Amlodipine intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN110372613B reveals a metal-free route to 2,3,6-trisubstituted pyrazine N-oxides. Mild conditions ensure high purity and cost-effective manufacturing for global supply chains.
Patent CN104024201B details a selective vanadium-catalyzed oxidation of nerolidol to farnesal, offering cost reduction in pharma intermediate manufacturing and enhanced supply reliability.
Patent CN108299302A details a novel 3-step synthesis for 3-acetylpyrazole, offering safer operations and scalable production for global pharmaceutical supply chains.
Novel phthalate condensation route offers high purity and scalable production for pharmaceutical and dye intermediates, reducing toxic solvent usage significantly.
Novel metal-free fluorination method ensures high purity and supply stability for pharmaceutical intermediates manufacturing.
Patent CN108484509B reveals a novel organocatalytic route for high-purity spiro compounds. Discover cost-effective manufacturing and scalable supply chain solutions.
Discover the novel B(C6F5)3 catalyzed synthesis of 2,4,6-triaryl pyridines. A cost-effective, scalable solution for high-purity pharmaceutical and agrochemical intermediates.
Discover a novel selenium-catalyzed method for propargyl alpha-amino boronate synthesis. Offers mild conditions, broad substrate scope, and cost-effective manufacturing for pharmaceutical intermediates.